Mettler-Toledo International reported first-quarter 2026 results on May 7, with net sales of $947.1 million, up 7% in reported terms and 3% in local currency. GAAP diluted EPS was $8.33 versus $7.81 a year earlier; adjusted diluted EPS rose 9% to $8.91. Management raised full-year 2026 guidance to roughly 4% local-currency sales growth and adjusted EPS of $46.30 to $46.95.
The Q1 release does not break out process analytics as a reportable segment - it sits inside the Industrial business - but on the May 8 earnings call, CEO Patrick Kaltenbach was asked directly about its trajectory. He framed process analytics as “a low single-digit contribution in revenues” but characterised it as “doing extremely well,” tied to “all these build-outs in semiconductor, including, by the way, data centers, where these things are also used for cooling systems.” On the bioprocessing side, Kaltenbach pointed to a recently launched glucose sensor as evidence of continued portfolio expansion for biopharma customers, alongside ongoing strength in GLP-1 manufacturing build-outs. Other launches highlighted on the call sat in the lab segment - the EasyMax Advanced automated reactor, the InMotion PX One autosampler for density and refractive-index work, and an M50 R-series metal detector for industrial - but the process analytics commentary was firmly on the sensor and analyzer side serving semiconductor ultra-pure water and bioreactor monitoring.
For process-analytics buyers, two readthroughs are worth noting. First, the semiconductor and data-center cooling angle is now an explicit growth narrative from one of the larger inline-sensor vendors, which means more vendor investment in ultra-pure water conductivity, dissolved oxygen, and silica monitoring is likely to follow. Second, the bioprocessing-sensor cadence - glucose joining the established pH, DO, CO2, and turbidity lineup - reflects where biopharma customers want richer inline data, complementing the Raman and NIR options that dominate API-side measurement. Segment-level reporting still does not disaggregate process instruments from the rest of Industrial, so investors and procurement teams will continue to triangulate from call commentary rather than from the press release alone.